Extantia
To add a bio or update investment portfolio, please click update information.
Investment Portfolio


Epoch Biodesign raises £9m in funding from lululemon and leading VCs for enzymatic nylon recycling
Epoch Biodesign develops enzymatic recycling technology that converts waste nylon materials back into their original chemical components. It enables manufacturers to produce new nylon without using virgin feedstock, helping apparel and automotive companies reduce reliance on raw materials.


Uplift360 raises a £6.4m seed round led by Extantia to recover and reuse high-value composite waste
Uplift360 develops chemical processes to recover and regenerate advanced composite materials. It enables aerospace and industrial companies to reuse high-value materials that would otherwise become waste.


AssetCool raises £10m Series A led by Energy Impact Partners to scale robotic grid upgrade technology globally
AssetCool develops robotic systems that apply advanced coatings to power lines, increasing grid capacity without replacing existing infrastructure.


Epoch Biodesign raises £14m Series A led by Extantia Capital to scale plastic-eating enzyme technology
Epoch Biodesign uses engineered enzymes to break down plastic waste into reusable chemical building blocks, enabling higher-quality recycling at industrial scale.


Modern Synthesis raises £4.5m seed extension led by Extantia to scale biomaterials for fashion
Modern Synthesis creates biomaterials by combining bacterial nanocellulose with natural fibres, producing durable alternatives to leather and synthetic fabrics for fashion brands.
- 2(12 months)
- extantia.com
- Update Information
More venture news
- 19 Aug 2026

EcoNomad SolutionsEcoNomad Solutions raises £400k in funding led by British Design Fund for small-farm waste-to-energy systems
EquityAgriculture - 19 Aug 2026

Singular PhotonicsSingular Photonics raises £1.6m in funding led by ACF Investors to build single-photon image sensors that analyse light as it lands
EquityDeep Tech - 5 Aug 2026

VisaDocVisaDoc secures a six-figure investment from Mercia to automate the visa process for business travellers
EquityLegal